Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Caribou Biosciences, Inc. - Common Stock (NQ:CRBU)

0.4601 -0.0099 (-2.11%)
Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Caribou Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Caribou Biosciences Announces Proposed Public Offering of Common Stock
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
2 Magnificient Growth Stocks to Buy in July ↗
These two growth stocks might be incredibly undervalued right now. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Buy for Long-Term Gains
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors. 
Via MarketBeat
Topics ETFs Economy
News headline image
Caribou Biosciences: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Pfizer Just Invested $25 million In This Biotech
Pfizer's investment propels Caribou Biosciences' stock and fuels optimism for its lead candidates: CB-010 and CB-011, both currently in phase 1 trials. 
Via MarketBeat
News headline image
Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About... Yet ↗
Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be... 
Via Benzinga
News headline image
Nasdaq Drops Over 100 Points; Genius Sports Shares Spike Higher ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday. The Dow traded down 1.09% to 33,913.56 while the NASDAQ fell 0.96% to 13,659.77. The... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Moves Lower; ISM Services PMI Surges In June ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Thursday. The Dow traded down 1.38% to 33,814.23 while the NASDAQ fell 1.37% to 13,602.19. The S&P 500,... 
Via Benzinga
News headline image
Why Shares of Caribou Biosciences Are Skyrocketing Today ↗
The company's shares spiked after Pfizer bought $25 million of Caribou stock. 
Via The Motley Fool
News headline image
The $25 Million Reason Caribou Biosciences (CRBU) Stock Is Soaring Today ↗
Caribou Biosciences (CRBU) stock is taking off on Thursday after the gene-editing company announced an investment from Pfizer (PFE). 
Via InvestorPlace
News headline image
Pfizer (NYSE: PFE) Invests $25 Million in Caribou Biosciences (NASDAQ: CRBU)
On July 6, 2023, Caribou Biosciences, Inc., a significant player in the field of CRISPR genome-editing biopharmaceuticals, announced a $25 
Via Spotlight Growth
News headline image
Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session ↗
Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer. 
Via Benzinga
News headline image
Pfizer Is Driving Caribou Biosciences Stock Higher Today: What's Going On? ↗
Caribou Biosciences, Inc. (NASDAQ: CRBU) shares are racing higher on Thursday after the company announced a $25 million equity investment from 
Via Benzinga
News headline image
Dow Tumbles Over 300 Points; US Jobless Claims Increase More Than Projected ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday. Following the market opening Thursday, the Dow traded down 0.96% to 33,958.13 while the NASDAQ fell 1.06%... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Caribou Biosciences to Participate in Upcoming Investor Conferences
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
Caribou Biosciences, Inc. (NASDAQ:CRBU) Long Term Investor Alert: Investigation over Possible Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 05/22/2023 -- Certain directors of Caribou Biosciences, Inc. are under investigation concerning potential breaches of fiduciary duties. 
Via SBWire
News headline image
Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
Caribou Biosciences to Participate in Upcoming Investor Conferences
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
Caribou Biosciences Presents New Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the 2023 AACR Annual Meeting
From Caribou Biosciences, Inc.
Via GlobeNewswire
News headline image
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Caribou Biosciences, Inc. (CRBU) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
CARIBOU DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CRBU FINAL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action - CRBU
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
NASDAQ:CRBU Investor Alert: Deadline on April 11, 2023 in Lawsuit Against Caribou Biosciences, Inc. Coming Up ↗
San Diego, CA -- (SBWIRE) -- 04/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on April 11, 2023 in the lawsuit filed for certain investors of Caribou Biosciences, Inc.... 
Via SBWire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.